Physician

Oncology

Dr. Geoffrey S. Kim, MD

Geoffrey is an expert in the field of Oncology. He went to medical school at Albert Einstein College of Medicine. Geoffrey has written publications. He has 5 publications published with PubMed. The lastest paper is: 'Successes and Challenges of PARP Inhibitors in Cancer Therapy.'

Publications

FDA Approval: Palbociclib for the Treatment of Postmenopausal Patients with Estrogen Receptor-Positive, HER2-Negative Metastatic Breast Cancer.
FDA Approval Summary: Vemurafenib for Treatment of Unresectable or Metastatic Melanoma with the BRAFV600E Mutation.
Vandetanib for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease: u.s. Food and...
Successes and Challenges of PARP Inhibitors in Cancer Therapy.

Schools

New York Medical College

Doctors Specialties

Medical Oncology
Oncology

Accepted Insurances

Education

National Institutes of Health Clinical Center
Albert Einstein College of Medicine

Helpful Reviews

Give Anonymous Review

Similar Doctors

	Dr. Kieron M. Dunleavy, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Alain Thibault, MD
	Dr. Robert L. Ramsey, MD
	Dr. Stanley Lipkowitz, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. James L. Gulley, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Ronald E. Gress, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Susan E. Bates, MD
	Dr. C N. Coleman, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Richard A. Binder, MD This Doctor is OpenDoctor Recommended.
	Dr. Ralph V. Boccia, MD This Doctor is OpenDoctor Recommended. This doctor has more publications